June 18 (SeeNews) - Irish, Dutch and Croatian companies are among the eight candidates that have submitted letters of intent (LoI) for the acquisition of shares and recapitalization of the Zagreb-based Institute of Immunology, IMZ, a local state-run maker of immunobiological medicines, a bourse filing indicated on Wednesday.